Equities research analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Get Free Report) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock.
Ampio Pharmaceuticals Stock Performance
NYSE:AMPE opened at $0.00 on Friday. The stock’s 50-day moving average is $0.02 and its 200-day moving average is $0.02. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47. The stock has a market cap of $2,964.00, a P/E ratio of 0.00 and a beta of 3.71.
Ampio Pharmaceuticals Company Profile
Recommended Stories
- Five stocks we like better than Ampio Pharmaceuticals
- Best Aerospace Stocks Investing
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- ETF Screener: Uses and Step-by-Step Guide
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- How to buy stock: A step-by-step guide for beginnersÂ
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.